Current News

Contact | Print version | Send article | RSS feed

genOway and Boehringer Ingelheim reinforce their collaboration

10 Jul 2006 - genOway reports a collaboration with Boehringer Ingelheim for the development of experimental research models. This collaboration has been recently reinforced and now includes several innovative technological solutions developed by genOway to create more powerful research models.
 
genOway uses its technologies and expertise to develop research models for gene targets provided by Boehringer Ingelheim. The resulting models are used in Boehringer Ingelheim's drug discovery research activities, for gene function analysis as well as for the testing of novel drug candidates. Financial conditions and therapeutic areas of interest are not disclosed.
 
genOway's expertise and in the field of transgenesis has led to the development of several cutting-edge proprietary technologies. These technologies enhance the predictability, security and robustness of the developed models. genOway has a complete range of innovative technological solutions aimed at increasing the predictability and efficacy of target validation, drug screening and pharmacological / toxicological studies.